Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART)

Journal of Mental Health Policy and Economics

Volumn 12, Issue 4, 2009, Pages

  Rothbard, Aileen B ^a,b   Lee, Sungeun ^c   Blank, Michael B ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ATYPICAL ANTIPSYCHOTIC AGENT;

ADULT; ARTICLE; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAID; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; MOOD DISORDER; OUTPATIENT CARE; PHARMACY; REIMBURSEMENT; SCHIZOPHRENIA; URBAN AREA;

ADULT; AGE DISTRIBUTION; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HEALTH EXPENDITURES; HEALTH SERVICES; HIV INFECTIONS; HUMANS; INSURANCE CLAIM REVIEW; MALE; MEDICAID; MENTAL DISORDERS; MIDDLE AGED; PUBLIC ASSISTANCE; SEX DISTRIBUTION; UNITED STATES; YOUNG ADULT;

EID: 75749103736     PISSN: 10914358     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Blank MB, Mandell DS, Aiken L, and Hadley TR. Co-occurrence of HIV and serious mental illness among Medicaid recipients. Psychiatr Serv 2002; 53: 868-873.
2. Rosenberg SD, Trumbetta SL, Mueser KT, Goodman LA, Osher FC, Vidaver RM, Metzger DS. Determinants of risk behavior for human immunodeficiency virus/acquired immunodeficiency syndrome in people with severe mental illness. Compr Psychiatry 2001; 42: 263-271.
3. Brunette MF, Mercer CC, Carlson CL, Rosenberg SD, Lewis BF. HIV-related services for persons with severe mental illness: Policy and practice in New Hampshire community mental health. J Behav Health Serv Res 2000; 27: 347-353.
4. Rothbard AB, Metraux S, and Blank MB. Cost of care for Medicaid recipients with serious mental illness and HIV infection or AIDS. Psychiatr Serv 2003; 54: 1240-1246.
5. Rothbard AB, Miller K, Lee, S, Blank MB. Revised cost estimates of Medicaid recipients with serious mental illness and HIV/AIDS. Psychiatr Serv 2009; 60: 974-977.
6. Bogart LM, Fremont AM, Young AS, Pantoja P, Chinman M, Morton S, Koegel P, Sullivan G, Kanouse DE. Patterns of HIV care for patients with serious mental illness. AIDS patient care and STDs 2006; 20: 175-182.
7. Walkup JT, Sambamoorthi U, Crystal S. Use of newer antiretroviral treatments among HIV-infected Medicaid beneficiaries with serious mental illness. J Clin Psychiatry 2004; 65: 1180-1189.
8. Himelhoch S., Moore, R.D., and Treisman, G. Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy? J Acquir Immune Defic Syndr 2004; 37: 1457-1463.
9. Fremont AM, Young AS, Chinman M, Pantoja P, Morton S, Koegel P, Sullivan G, Kanouse DE. Differences in HIV care between patients with and without severe mental illness. Psychiatr Serv 2007; 58: 681-688.
10. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. Defining comorbidity: implications for understanding health and health services. Ann Fam Med 2009; 7: 357-363.
11. Lurie N, Popkin M, Dysken M, Moscovice I, Finch M. Accuracy of diagnoses of schizophrenia in Medicaid claims. Hosp Community Psychiatry 1992; 43: 69-71.
12. Olfson M., Marcus S, Weissman MM, Jensen PS. National trends in the use of psychotropic medications by children. J Am Acad Child Adolesc Psychiatry 2002; 41: 514-521.
13. Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL. Cost Subcommittee of the HIV/AIDS Treatment Adherence, Health Outcomes, and Cost Study Group. Utilization of Mental Health and Substance Abuse Care for People Living with HIV/AIDS, chronic mental illness, and substance abuse disorder. J Acquir Immune Defic Syndr 2008; 47: 449-458.
14. Bozzette SA, Joyce G, McCaffrey DF, Leibowitz AA, Morton SC, Berry SH, Rastegar A, Timberlake D, Shapiro MF, Goldman DP, for The HIV Cost and Services Utilization Study Consortium. Expenditures for the Care of HIV-infected Patients in the Era of Highly Active Antiretroviral Therapy. N Engl J Med 2001; 344: 817-882.
15. Chen RY, Accortt NA, Westfall AO. Distribution of health care expenditures for HIV-infected patients. Clin Infect Dis 2006; 42: 1011-1013.
16. Schackman BR, Gebo KA, Walensky RP, Losina E, Muccio T, Sax PE, Weinstein M C, Seage GR, Moore RD, Freedberg KA. The lifetime cost of current human immunodeficiency virus care in the United States. Med Care 2006; 44: 990-997.
17. Rothbard AB, Kuno E, Hadley TR, Dogin J. Psychiatric Service Use and Cost for Persons with Schizophrenia in a Medicaid Managed Care Program. J Behav Health Serv Res 2003; 31: 1-12.
18. Rothbard AB, Kuno E . Comparison of Alcohol Treatment Utilization and Cost following Implementation of Medicaid Managed Care. Am J Manag Care 2006; 12: 285-296.
19. Roberts RR, Kampe LM, Hammerman M, Scott D, Soto T, Ciavarella GG, Rydman RJ, Gorosh K, Weinstein RA. The cost of care for patients with HIV from the provider economic perspective. AIDS patient care and STDs 2006; 20: 876-886.
20. Fasciano NJ, Cherlow AL, Turner BJ, Thornton CV. Profile of Medicare beneficiaries with AIDS: application of an AIDS casefinding algorithm. Health Care Financ Rev 1998; 19: 19-38.